Skip to main content
Erschienen in: Intensive Care Medicine 3/2005

01.03.2005 | Correspondence

Safety of endotoxin challenge in healthy volunteers: bradycardia

verfasst von: Bernd Jilma

Erschienen in: Intensive Care Medicine | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Excerpt

Sir: human endotoxemia is a well-standardized and safe model to study systemic inflammation or coagulation [1, 2] and the pharmacodynamic effects of novel therapeutic agents during early phase drug development [3]. Recently, van Eijk et al. have reported the occurrence of severe bradycardia or protracted asystole after infusion of endotoxin [4]. They had observed two cases during their study. In addition, two further cases were identified after review of the published literature [5] and interviews by three established investigators, who challenged approximately 2,200 subjects with Reference Endotoxin E. coli: 0113 in the last 25 years [4]. …
Literatur
1.
Zurück zum Zitat Fiuza C, Suffredini AF (2001) Human models of innate immunity: local and systemic inflammatory responses. J Endotoxin Res 7:385–388 Fiuza C, Suffredini AF (2001) Human models of innate immunity: local and systemic inflammatory responses. J Endotoxin Res 7:385–388
2.
Zurück zum Zitat Martich GD, Boujoukos AJ, Suffredini AF (1993) Response of man to endotoxin. Immunobiology 187:403–416PubMed Martich GD, Boujoukos AJ, Suffredini AF (1993) Response of man to endotoxin. Immunobiology 187:403–416PubMed
3.
Zurück zum Zitat Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FB Jr, Ribel MC, Erhardtsen E, Handler S, Eichler HG (2002) Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin Pharmacol Ther 72:403–410 Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FB Jr, Ribel MC, Erhardtsen E, Handler S, Eichler HG (2002) Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin Pharmacol Ther 72:403–410
4.
Zurück zum Zitat van Eijk LT, Pickkers P, Smits P, Bouw MP, van der Hoeven JG (2004) Severe vagal response after endotoxin administration in humans. Intensive Care Med (E-pub ahead of publication) van Eijk LT, Pickkers P, Smits P, Bouw MP, van der Hoeven JG (2004) Severe vagal response after endotoxin administration in humans. Intensive Care Med (E-pub ahead of publication)
5.
Zurück zum Zitat Williams WV, Fullerton T, Fox JC, Enslin MB, Murray L, Jorkasky D (2000) Asystole following endotoxin administration. J Endotoxin Res 6:303–306PubMed Williams WV, Fullerton T, Fox JC, Enslin MB, Murray L, Jorkasky D (2000) Asystole following endotoxin administration. J Endotoxin Res 6:303–306PubMed
6.
Zurück zum Zitat Pernerstorfer T, Schmid R, Bieglmayer C, Eichler HG, Kapiotis S, Jilma B (1999) Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther 66:51–57 Pernerstorfer T, Schmid R, Bieglmayer C, Eichler HG, Kapiotis S, Jilma B (1999) Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther 66:51–57
Metadaten
Titel
Safety of endotoxin challenge in healthy volunteers: bradycardia
verfasst von
Bernd Jilma
Publikationsdatum
01.03.2005
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2562-z

Weitere Artikel der Ausgabe 3/2005

Intensive Care Medicine 3/2005 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.